Form D · Biotechnology

A2 Biotherapeutics, Inc.

Agoura Hills, CA · CIK 0001828750

Offering snapshot reported Dec 16, 2022 · SEC filing

Reported sold
$71.6M
Offering amount: $71.6M
Investors reported
28
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Nov 4, 2022
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$35.8M$71.6MNov 17, 2022: $60,855,105.00Nov 17, 2022Dec 16, 2022: $71,605,105.00Dec 16, 2022

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

  • Reported sold$60,855,105 → $71,605,105
  • Reported investors26 → 28

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Dec 16, 2022Amendment$71,605,105$10,750,000vs Nov 17, 202228SEC filing
Nov 17, 2022Initial$60,855,105No comparison26SEC filing
Oct 26, 2020Amendment$71,527,099$13,500,000vs Oct 20, 202013SEC filing
Oct 20, 2020Initial$58,027,099No comparison13SEC filing

Offering details

Securities
Equity, Option to acquire
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-465076

Source: Form D, filed Dec 16, 2022. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Srini Akkaraju Director
Madhavan Balachandran Director
Scott Foraker Director, Executive
Michael Gallo Director
William Go Executive
David Goeddel Director
C. Alexander Kamb Director
Alexander Kamb Director, Executive
Susan L. Kelley Director
Helen S. Kim Director
Thomas Leung Executive
Jakob Loven Director
David Lucas Executive

Issuer details

Industry: Biotechnology (See others in industry)

Address:
30301 Agoura Road, #210
Agoura Hills, CA, 91301